She is
celebrated as South Africa’s “golden girl”. But Olympic champion Caster Semenya
is now pushing the sports world to potentially dash through a challenging
hurdles’ course peppered with issues of gender, hormones and performance.
Amid
the raging controversy over new eligibility regulations for female
classification introduced by the International Association of Athletics
Federations (IAAF), the basic question of who is a male or female is becoming
increasingly irrelevant.
e IAAF
regulations for athletes with differences of sex development. AP
The
IAAF regulations for athletes with differences of sex development (DSD) have
been challenged by middle-distance runner Semenya, a two-time Olympic champion
in the 800 metres, in the Court of Arbitration for Sport (CAS). The Lausanne
(Switzerland)-based court is an international quasi-judicial organisation that
deals with disputes within sports, mainly anti-doping matters, athletes’
rights, commercial disputes and eligibility issues.
The DSD
rules are the extension of the IAAF hyperandrogenism regulations that were set
aside by CAS in July 2015 when Indian sprinter Dutee Chand questioned her ban
from athletics because of her higher testosterone levels. The CAS, while
staying the rules, gave the IAAF two years to bring forward evidence that
female athletes would gain an advantage of 10-12 per cent over their rivals
because of the extra testosterone in their bodies. Otherwise, it seemed to
agree, it would be similar to other natural advantages that athletes gain
because of long limbs or broad feet.
Hyperandrogenism
is a medical condition that sees disproportionate levels of androgens, or male
sex hormones such as testosterone, in the female body and the associated
effects.
Advantage is not what CAS is looking for
Instead
of going back to the CAS panel with its modified rules, the IAAF brought in an
entirely different set of rules based on research done by scientists engaged by
it. These were scheduled to be effective from November last year but kept in
abeyance following the Semenya appeal to CAS. The IAAF research has not been
able to show the 10 per cent advantage that CAS talked about, and only at much
lower levels.
If
Semenya prevails, as several activists and many observers hope would be the
case, there could be another attempt by sports organisations to bring some
other regulations or even suggest a third category for transgender or
transsexual or inter-sex athletes. All Olympic sports are dependent on the
International Olympic Committee (IOC) laying down regulations and the
organisation is waiting for the Semenya case to be resolved.
Semenya,
28, looks unbeatable over 800m today and she is gradually gaining the same
superiority over the 1,500m. Following the stay of the hyperandrogenism
regulations, Semenya has clocked national records of 1:55.28 (2016), 1:55.16
(2017) and 1:54.25 (2018). Previously, the runner had clocked a sub-1:56 in the
2009 World Championships, winning in 1:55.45.
Semenya
was apparently asked to undergo hormone therapy to reduce testosterone levels
after the 2009 World championships. The South African slowed down considerably
till receiving a boost from the Dutee Chand ruling in 2015. If there is a
classic example of how much additional testosterone would matter to a female
athlete, all that is required for anyone is to study Semenya’s timings.
The
efforts of the IAAF and of the IOC to devise a method that would not be
intrusive and would be based on scientific principles to determine eligibility
rules for females have met with more opposition today than there was in the
1990s. The pro-Semenya lobby does not agree that testosterone is the
determining factor in athletics advantage. It has found flaws in the research
funded by the IAAF and has questioned the idea of healthy humans being advised
to take drugs for a non-existent “disease”. It has also opined that there was
so much of grey area in androgen sensitivity that athletes insensitive to
testosterone might fall victim to the new rules and processes.
Should law decide who is a female?
Should
the law of a country determine who is a female, as many have argued? Suppose
there is no such law in a country, who will certify someone is a female or transgender
or intersex?
Today,
after many years of explaining testosterone levels, gender ambiguity,
conditions that may lead to confusion and exceptions including polycystic ovary
syndrome (PCOS), the IAAF, in its statements, has mentioned “testes” as a crucial
factor in its bid to bring a “level-playing field” for women. How everyone
missed this point all these years is a mystery.
The
IAAF DSD regulations, however, do not mention “testes” that are the primary
source of testosterone in males. Females also produce testosterone from ovaries
and adrenal gland, but in much smaller quantities compared to males.
In a
subject that is complex and open to debate, scientists have sniped at each
other without providing a solution. Androgen insensitivity in a female having
one of the seven DSD conditions listed by the IAAF may lead to a state where
the individual is incapable of utilising the testosterone produced. The IAAF
has covered this situation by mentioning that in all cases the athletes who may
be selected to undergo tests would be fully androgen sensitive. Critics say
this is complicated science and it is difficult to establish androgen
insensitivity in many cases.
The
normal testosterone levels are above 10 nanomoles per litre for males and 0.1
to 2.8nmol per litre for females. The IAAF has fixed 5nmol per litre for DSD
females. If exceeded, they would be ineligible to compete in select women’s
events ranging from 400m to 1,500m and the mile at the international level,
though they could compete at the national level and other meets that are not
specified.
Athletes shy of coming forward
The cry
of “discrimination” is loud across the world. From a United Nations group on
human rights to scientists to activists to writers all are prepared to brand
the IAAF as guilty. The organisation has said it has the support of a wide
representation of the athletics community. Most of them are wary of coming
forward, though. This, in a way, has harmed the interests of the
non-hyperandrogenic females.
World
marathon record holder Paula Radcliffe of Britain has suffered in expressing
her opinion in favour of regulations, but someone like Kelly Holmes, also of
Britain, a double gold winner in the Olympics, received encouraging support
from her followers, when she tweeted: “Anyone can live how they want to live,
but let women have their rights too!” Tennis great Billie Jean King – who
famously beat 55-year-old retired male player Bobby Riggs when she was 29 in
the Battle of the Sexes match in the 1970s – has offered Caster Semenya her
full support. However, fellow legend Martina Navratilova has said that allowing
transgender women to compete in women’s sport is “insane”.
Only a
few active athletes have so far tried to show the hopelessness in competing
against Semenya or a couple of others who are yet to sweep the races like the
South African but are still formidable. There is a genuine apprehension that if
Semenya wins her appeal in CAS, the stage might be set for hyperandrogenic
athletes to be prepared consciously and methodically by nations that are out to
gain Olympic glory. India might not be an exception in this hyperandrogenic
exercise. If doping could be institutionalised to the extent that it has been
shown to be in Russia, the testosterone-driven female athletes, supported by
the State, could well become a reality, many have argued. CAS holds the key to
the future of women’s sports in the world.